Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

NP2 Enkephalin For Treatment of Intractable Cancer Pain

ClinicalTrials.gov ID: NCT01291901

Public ClinicalTrials.gov record NCT01291901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double Blind, Placebo-controlled, Multicenter Study to Investigate the Impact of NP2 in Subjects With Intractable Pain Due to Malignancy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to examine the impact of intradermal delivery of NP2 on pain scores and pain medication usage in subjects with intractable pain due to malignant disease. A second purpose is to confirm safety and secondary efficacy measurements.

Study identification

NCT ID
NCT01291901
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Diamyd Inc
Industry
Enrollment
33 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2011 (Type not available)
Primary completion
Jul 2012 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Aug 8, 2014

2011 – 2013

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
HOPE Research Institute Phoenix Arizona 85050 —
Arizona Clinical Research Center Tucson Arizona 85715 —
Compassionate Cancer Care Medical Group, Inc. Corona California 92879 —
Cancer Care Associates Fresno California 93720 —
TriWest Research Associates La Mesa California 91942 —
White Memorial Medical Center Los Angeles California 90033 —
Hematology Oncology Associates Oakland California 94609 —
Advanced Pharma CR Miami Florida 33175 —
Better Health Clinical Research Inc Newnan Georgia 30265 —
Christie Clinic Champaign Illinois 61820 —
Global Scientific Innovations Evansville Indiana 47714 —
Montana Cancer Institute Foundation Missoula Montana 59802 —
Center for Clinical Research Winston-Salem North Carolina 27103 —
Signal Point Clinical research Center Middletown Ohio 45042 —
Pain Research of Oregon Eugene Oregon 97401 —
Hematology Oncology Associatesof Rhode Island Cranston Rhode Island 02920 —
Medical Therapy and Research San Antonio Texas 78217 —
Medical Oncology Associates Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01291901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01291901 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →